ACTRN12611000571976招募中4 期
Efficacy of highly selective-a-1A-adrenoceptor antagonist in expulsive therapy of lower ureteral stones
Chung Jing Wang0 个研究点目标入组 45 人开始时间: 2011年6月3日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 20 Years 至 60 Years（—）
- 性别
- All
入选标准
- •symptomatic radiopaque lower ureteral stones >5mm aged between 20 and 60 years old
排除标准
- •Subjects with urinary tract infections, high-grade hydronephrosis, diabetes, ulcers, or a history of hypersensitivity toa-1 blocker and pregnant women were excluded. Patients with a history of spontaneous stone expulsion, hypotension, or those found to have systolic blood pressure lower than 110 mmHg were also excluded.
研究者
相似试验
尚未招募
不适用
The effects of selective alpha-1-adrenergic receptor antagonists in patients with lower urinary tract symptoms caused by benign prostatic hyperplasiawho failed to obtain sufficient efficacy by previous alpha-1-blockades. . A comparison of Naftopidil or Silodosin.Benign Prostatic HyperplasiaJPRN-UMIN000003609Kansai Medical University Takii Hospital100
进行中（未招募）
不适用
Effect of selective alpha 1A receptor antagonists on the iris dilator muscleEffect of selective alpha 1A receptor antagonists on the iris dilator muscleEUCTR2015-003061-28-ATVienna Institute for Research in Ocular Surgery
进行中（未招募）
不适用
Impact of selective alpha 1A receptor antagonists on the pupil size after instillation of tropicamide 0.5% and phenylephrine 10%Impact of selective alpha 1A receptor antagonists on the pupil size after instillation of tropicamide 0.5% and phenylephrine 10%EUCTR2015-003064-36-ATVienna Institute for Research in Ocular Surgery
招募中
2 期
Doxazosin to Prevent Severe COVID-19 (CALM-COVID Trial)CTRI/2021/09/036099Johns Hopkins University School of Medicine
进行中（未招募）
2 期
Terazosin and Parkinson's Disease Extension StudySymptomatic Parkinson DiseaseREM Sleep Behavior DisorderPre-motor Parkinson's DiseaseNCT05109364Cedars-Sinai Medical Center15